Format

Send to

Choose Destination
Mult Scler. 2018 Sep 19:1352458518799583. doi: 10.1177/1352458518799583. [Epub ahead of print]

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

Author information

1
Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
3
Neuroscience Graduate Program, Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
4
Vanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
5
Neuroimaging Unit, Neuroimmunology Division, Vanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
6
Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
7
Department of Psychiatry and Behavioral Sciences, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, TN, USA/Veterans Affairs Tennessee Valley Healthcare System Geriatric Research, Education, and Clinical Center (VA TVHS GRECC), Nashville, TN, USA.
8
Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

Abstract

BACKGROUND:

Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T1- and T2-weighted magnetic resonance imaging (MRI). There is a need for high-resolution, clinically accessible imaging techniques that probe molecular changes in GM.

OBJECTIVE:

To study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0 Tesla (7T).

METHODS:

A total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI.

RESULTS AND CONCLUSION:

Glutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability ( p < 0.05). In addition, glutamate-sensitive contrast in the prefrontal cortex was significantly correlated with symbol digit modality test ( rS = -0.814) and choice reaction time ( rS = 0.772) scores in patients ( p < 0.05), suggesting that GluCEST MRI may have utility as a marker for GM pathology and CI.

KEYWORDS:

Multiple sclerosis; cognitive dysfunction; glutamate; gray matter; magnetic resonance imaging; prefrontal cortex

PMID:
30230400
DOI:
10.1177/1352458518799583

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center